GeneDx Holdings Corp. ( WGS) - Stock Earnings
WGS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -7.6 million USD | 116.7 million USD |
| 2025Q4 | -17.7 million USD | 121.0 million USD |
| 2026Q1 | -63.3 million USD | 102.3 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
WGS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -175.8 million USD | 202.6 million USD |
| 2024 | -52.3 million USD | 305.5 million USD |
| 2025 | -21.0 million USD | 427.5 million USD |
| 2026 Est. | — | — |
WGS
Price: $56.27
52 week price:
Earnings Per Share: -2.66 USD
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Market Capitalization: 1.6 billion